Plyometry and Tapping in the Functional Improvement of Non-professional Basketball Players

March 24, 2025 updated by: Rubén Cuesta-Barriuso, PhD, Universidad Católica San Antonio de Murcia

Plyometry and Tapping in the Functional Improvement of Non-professional Basketball Players. Randomised Clinical Study

Introduction. In basketball, the lower extremities have the highest prevalence of injury, regardless of gender and professional category.

Objective. To analyse the efficacy of a physiotherapy intervention using a protocol of plyometric exercises and dry needling in non-professional basketball athletes.

Methods. Randomised clinical study. 20 players will be randomised to an experimental group (plyometric exercises and dry needling of the gastrocnemius muscles) and a control group (plyometric exercises). The intervention will include 8 sessions over 4 weeks. The study variables will be: range of motion in dorsal flexion in loading (Leg Motion®) and unloading (goniometer) and vertical jump (MyJump2®).

Expected results. An intervention of plyometric exercises and dry needling produces significant differences in range of motion and vertical jump in basketball players, compared to the isolated administration of plyometric exercises.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Asturias
      • Oviedo, Asturias, Spain, 33006
        • Rubén Cuesta-Barriuso

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Non-professional basketball players who are in competition.
  • Subjects over 18 years of age
  • Athletes competing in the first men's division of the basketball federation of the Region of Murcia.
  • Sign the informed consent document.

Exclusion Criteria:

  • Subjects who are injured at the time of data collection.
  • Subjects who are unable to attend all training sessions during the duration of the research.
  • Athletes with apprehension to dry needling.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
The intervention period will last 4 weeks, with a periodicity of 2 weekly sessions of 30 minutes each. All interventions will take place in the sports facilities of both clubs. The interventions will be carried out by the principal investigator of the study. The 10 players assigned to the experimental group will perform plyometric exercises and will undergo dry needling of the gastrocnemius (gastrocnemius muscle) and the control group (plyometric exercises and dry needling of the gastrocnemius muscle).

The athletes included in the experimental group will undergo an intervention using a plyometric exercise protocol, 2 days a week, and dry needling of the gastrocnemius muscles will be applied in a weekly session.

To perform the dry needling intervention, 0.3x50mm disposable steel needles will be used, applying the "quick in-and-out" technique. To do this, first of all, the intervention area will be cleaned with alcohol and sterile gloves will be used to perform the manoeuvre in complete safety. The active or latent trigger point is then located within the taut band by inserting the needle deeper and deeper, and then moving the needle up and down in search of a local contraction response. A maximum of 8 insertions or up to the athlete's tolerance limit will be applied.

Active Comparator: Control group
The 10 players assigned to the control group will perform plyometric exercises.
The athletes included in the control group will perform an intervention using a plyometric exercise protocol, 2 days a week, under the same conditions as the experimental group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline range of motion in loaded dorsal flexion after treatment and at 4 weeks
Time Frame: Screening visit, within the first seven days after treatment and after four weeks follow-up visit
Loaded dorsiflexion of the ankle will be assessed using the Leg Motion® device. This test consists of placing the athlete barefoot with the foot on the measuring scale of the instrument, requesting maximum knee flexion without lifting the heel. The test is performed 3 times and the average value is used in the data analysis. The unit of measurement is the maximum distance, measured in centimetres, between the toe and the metal bar. The greater the distance, the greater the dorsiflexion in ankle loading.
Screening visit, within the first seven days after treatment and after four weeks follow-up visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline range of motion in unloaded dorsal flexion after treatment and at 4 weeks
Time Frame: Screening visit, within the first seven days after treatment and after four weeks follow-up visit
Passive dorsiflexion of the ankle shall be measured in the supine position using a universal goniometer. For this assessment, the axis of the goniometer is placed over the centre of the lateral malleolus, while the fixed arm is placed parallel to the fibula towards the head of the fibula, and the movable arm is placed parallel to the 5th metatarsal. The unit of measurement is a value in degrees, where the higher the graduation, the greater the ankle dorsiflexion.
Screening visit, within the first seven days after treatment and after four weeks follow-up visit
Change from baseline vertical jump after treatment and at 4 weeks
Time Frame: Screening visit, within the first seven days after treatment and after four weeks follow-up visit
The variable vertical jump height will be measured with the MyJump2® application. In this test, the evaluator stands 1.5 metres away from the athlete with the mobile phone at ground level. The player must perform a jump with both feet on the ground and the hands on the hips. When the athlete is in the flight phase, he/she should have both legs extended, while when landing, the first contact should be with the metatarsals. The unit of measurement of this tool is in centimetres, where the greater the distance, the greater the vertical jump.
Screening visit, within the first seven days after treatment and after four weeks follow-up visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2024

Primary Completion (Actual)

June 10, 2024

Study Completion (Actual)

July 1, 2024

Study Registration Dates

First Submitted

April 11, 2024

First Submitted That Met QC Criteria

April 11, 2024

First Posted (Actual)

April 16, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Bask-Pliomet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Basketball Players

Clinical Trials on Experimental group

Subscribe